Get started
ADDEX NADDEX NADDEX N

ADDEX N

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ADXN chart


Full chart

ADXN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.06 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
0.0538 CHF
Net income (FY)
‪−10.56 M‬ CHF
Revenue (FY)
‪1.62 M‬ CHF
Shares float
‪58.48 M‬
Beta (1Y)
0.72

Employees


Employees (FY)
23
Change (1Y)
−1 −4.17%
Revenue / Employee (1Y)
‪70.31 K‬ CHF
Net income / Employee (1Y)
‪−458.97 K‬ CHF

About ADDEX N


Sector
Health Technology
CEO
Timothy Dyer
Headquarters
Geneva
Website
addextherapeutics.com
Founded
2002
ISIN
CH0029850754
FIGI
BBG000LHBCW4
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ADXN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ADXN is 0.0530 CHF — it has decreased by −11.67% in the past 24 hours. Watch ADDEX N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange ADDEX N stocks are traded under the ticker ADXN.
ADXN stock has fallen by −11.67% compared to the previous week, the month change is a −9.86% fall, over the last year ADDEX N has showed a 15.22% increase.
We've gathered analysts' opinions on ADDEX N future price: according to them, ADXN price has a max estimate of 0.21 CHF and a min estimate of 0.21 CHF. Watch ADXN chart and read a more detailed ADDEX N stock forecast: see what analysts think of ADDEX N and suggest that you do with its stocks.
ADXN reached its all-time high on May 22, 2007 with the price of 75.0000 CHF, and its all-time low was 0.0362 CHF and was reached on Nov 29, 2023. View more price dynamics on ADXN chart.
See other stocks reaching their highest and lowest prices.
ADXN stock is 16.28% volatile and has beta coefficient of 0.72. Track ADDEX N stock price on the chart and check out the list of the most volatile stocks — is ADDEX N there?
Today ADDEX N has the market capitalization of ‪5.21 M‬, it has decreased by −0.67% over the last week.
Yes, you can track ADDEX N financials in yearly and quarterly reports right on TradingView.
ADDEX N is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ADXN earnings for the last quarter are −0.02 CHF per share, whereas the estimation was −0.01 CHF resulting in a −100.00% surprise. The estimated earnings for the next quarter are −0.01 CHF per share. See more details about ADDEX N earnings.
ADDEX N revenue for the last quarter amounts to ‪59.00 K‬ CHF, despite the estimated figure of ‪100.00 K‬ CHF. In the next quarter, revenue is expected to reach ‪100.00 K‬ CHF.
ADXN net income for the last quarter is ‪−1.53 M‬ CHF, while the quarter before that showed ‪12.88 M‬ CHF of net income which accounts for −111.88% change. Track more ADDEX N financial stats to get the full picture.
No, ADXN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 23.00 employees. See our rating of the largest employees — is ADDEX N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADDEX N EBITDA is ‪−4.74 M‬ CHF, and current EBITDA margin is −618.68%. See more stats in ADDEX N financial statements.
Like other stocks, ADXN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADDEX N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADDEX N technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADDEX N stock shows the sell signal. See more of ADDEX N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.